These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16611148)

  • 21. Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors.
    Shcherbakov D; Baev D; Kalinin M; Dalinger A; Chirkova V; Belenkaya S; Khvostov A; Krut'ko D; Medved'ko A; Volosnikova E; Sharlaeva E; Shanshin D; Tolstikova T; Yarovaya O; Maksyutov R; Salakhutdinov N; Vatsadze S
    ACS Med Chem Lett; 2022 Jan; 13(1):140-147. PubMed ID: 35043075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
    Zhang L; Lin D; Sun X; Curth U; Drosten C; Sauerhering L; Becker S; Rox K; Hilgenfeld R
    Science; 2020 Apr; 368(6489):409-412. PubMed ID: 32198291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 Fatty Acids in the Management of Epilepsy.
    Tejada S; Martorell M; Capó X; Tur JA; Pons A; Sureda A
    Curr Top Med Chem; 2016; 16(17):1897-905. PubMed ID: 26845549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabry disease.
    Schiffmann R
    Handb Clin Neurol; 2015; 132():231-48. PubMed ID: 26564084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside content of berries and roots of three typical Korean ginseng (Panax ginseng) cultivars.
    Kim YK; Yoo DS; Xu H; Park NI; Kim HH; Choi JE; Park SU
    Nat Prod Commun; 2009 Jul; 4(7):903-6. PubMed ID: 19731589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural plasticity of SARS-CoV-2 3CL M
    Kneller DW; Phillips G; O'Neill HM; Jedrzejczak R; Stols L; Langan P; Joachimiak A; Coates L; Kovalevsky A
    Nat Commun; 2020 Jun; 11(1):3202. PubMed ID: 32581217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases.
    Báez-Santos YM; Barraza SJ; Wilson MW; Agius MP; Mielech AM; Davis NM; Baker SC; Larsen SD; Mesecar AD
    J Med Chem; 2014 Mar; 57(6):2393-412. PubMed ID: 24568342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease.
    Li Q; Kang C
    Microorganisms; 2020 Aug; 8(8):. PubMed ID: 32824639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug design targeting the main protease, the Achilles' heel of coronaviruses.
    Yang H; Bartlam M; Rao Z
    Curr Pharm Des; 2006; 12(35):4573-90. PubMed ID: 17168763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential SARS-CoV-2 main protease inhibitors.
    Banerjee R; Perera L; Tillekeratne LMV
    Drug Discov Today; 2021 Mar; 26(3):804-816. PubMed ID: 33309533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
    Vuong W; Khan MB; Fischer C; Arutyunova E; Lamer T; Shields J; Saffran HA; McKay RT; van Belkum MJ; Joyce MA; Young HS; Tyrrell DL; Vederas JC; Lemieux MJ
    Nat Commun; 2020 Aug; 11(1):4282. PubMed ID: 32855413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SARS-CoV-2 main protease as drug target.
    Ullrich S; Nitsche C
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127377. PubMed ID: 32738988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
    Pillaiyar T; Manickam M; Namasivayam V; Hayashi Y; Jung SH
    J Med Chem; 2016 Jul; 59(14):6595-628. PubMed ID: 26878082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design.
    Hilgenfeld R
    FEBS J; 2014 Sep; 281(18):4085-96. PubMed ID: 25039866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A survey of isatin hybrids and their biological properties.
    Shu VA; Eni DB; Ntie-Kang F
    Mol Divers; 2024 Jun; ():. PubMed ID: 38833124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease.
    Mohebbi A; Eskandarzadeh M; Zangi H; Fatehi M
    PLoS One; 2024; 19(4):e0298201. PubMed ID: 38626042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19.
    Esam Z; Akhavan M; Lotfi M; Pourmand S; Bekhradnia A
    Chem Zvesti; 2023; 77(2):1129-1148. PubMed ID: 36312321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
    Elkaeed EB; Eissa IH; Elkady H; Abdelalim A; Alqaisi AM; Alsfouk AA; Elwan A; Metwaly AM
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease.
    Elkaeed EB; Youssef FS; Eissa IH; Elkady H; Alsfouk AA; Ashour ML; El Hassab MA; Abou-Seri SM; Metwaly AM
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.